JOHNSON & JOHNSON is 341.6x more valuable than RAPT Therapeutics, Inc. by market capitalization ($573.98 B vs $1.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RAPT | JNJ |
|---|---|---|
| Market cap | $1.68 B | $573.98 B |
| US-listed rank | #2231 | #20 |
| Revenue (latest FY) | $0.00 | $94.19B |
| Net income (latest FY) | -$129.87M | $26.80B |
| Net margin | - | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 569 | 984 |
JOHNSON & JOHNSON is 341.6x more valuable than RAPT Therapeutics, Inc. by market capitalization ($573.98 B vs $1.68 B).
In their latest fiscal years, RAPT Therapeutics, Inc. reported $0.00 in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: RAPT Therapeutics, Inc. and JOHNSON & JOHNSON, or browse the full rankings.